Health
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question – The Lancet
Since the onset of the COVID-19 pandemic, SARS-CoV-2 vaccine development has progressedat an unprecedented rate, with recent phase 3 trial data offering the tantalising…
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
Copyright © 2021 Elsevier Inc. except certain content provided by third parties.
Privacy Policy Terms and Conditions
Continue Reading
-
Noosa News22 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
General22 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
Noosa News24 hours agoGirl’s death in a Queensland cult
-
Noosa News13 hours agoQueensland government to review greenhouse gas emission reduction targets